retatrutide side effects phase 2 trial Long-Term Effects: What Current Data Show – Bolt Pharmacy Retatrutide Peptide Side Effects: My
Description
10.1016/S0735-1097(22)02516-5 76
Corcoran C et al
The trial included roughly 450 adults with obesity or who were overweight and had knee osteoarthritis
Common GLP-1 Inhibitors Some of the most commonly prescribed GLP-1 inhibitors include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Mounjaro) Exenatide (Byetta, Bydureon) These medications are most commonly administered in the form of weekly injections, but there are a few oral formulations available on the market as well
Third, retrospective observational studies have inherent limitations, including unmeasured or uncontrolled confounders and biases
